Market Closed -
Australian S.E.
11:28:11 16/05/2024 am IST
5-day change
1st Jan Change
0.995
AUD
-0.50%
0.00%
+63.11%
This article is reserved for members
Not a member ?
Free registration
Australian Shares Fall on Fading Rate Cut Hopes; BHP Slips 4% on Anglo American Bid Update
26/04
MT
EBR Systems on Track to Submit Cardiac Pacing Technology's Final Module to US FDA in Q3
26/04
MT
EBR Systems, Inc.(ASX:EBR) added to S&P/ASX All Ordinaries Index
18/03
CI
EBR Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
28/02
CI
1,104,030 Warrants of EBR Systems, Inc. are subject to a Lock-Up Agreement Ending on 24-NOV-2023.
24/11
CI
11,546,742 Options of EBR Systems, Inc. are subject to a Lock-Up Agreement Ending on 24-NOV-2023.
24/11
CI
5,785,188 CHESS Depositary Interests of EBR Systems, Inc. are subject to a Lock-Up Agreement Ending on 24-NOV-2023.
24/11
CI
EBR Systems, Inc. Announces Positive Results from First-In-Human Fully Leadless CRT in the US, Published in the Journal of the American College of Cardiology
25/23/25
CI
Ebr Systems, Inc. Announces Chief Financial Officer Changes
11/23/11
CI
EBR Systems, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
29/23/29
CI
Eletrobras Says Wilson Ferreira Junior Resigned
15/23/15
MT
EBR Systems Draws Down Second Tranche of AU$30 Million Under Growth Capital Facility
03/23/03
MT
EBR Systems Opens Up to AU$5 Million Securities Purchase Plan
30/23/30
MT
EBR Systems Raises AU$30 Million to Expand Sales Team, Fund FDA Approval; Shares Down 6%
23/23/23
MT
EBR Systems Unlocks Second Tranche of AU$30 Million Under Growth Capital Facility
06/23/06
MT
Ebr Systems' Pivotal Solve-Crt Trial Meets Endpoints
22/23/22
CI
EBR Systems Says No Exposure to Silicon Valley Bank Collapse
13/23/13
MT
EBR Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
28/23/28
CI
EBR Systems Appoints Chief Scientific Officer
22/23/22
MT
EBR Systems, Inc. Appoints Dr. Rick Kuntz as Consulting Chief Scientific Officer
22/23/22
CI
550,181 CHESS Depositary Interests of EBR Systems, Inc. are subject to a Lock-Up Agreement Ending on 18-NOV-2022.
18/22/18
CI
EBR Systems, Inc. Provides an Update Regarding the Wise System
21/22/21
CI
3,063,365 Warrants of EBR Systems, Inc. are subject to a Lock-Up Agreement Ending on 3-OCT-2022.
03/22/03
CI
EBR Systems, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
29/22/29
CI
EBR Systems Validates Efficacy of Cardiac Pacing Device; Shares Fall 3%
10/22/10
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
EBR Systems, Inc. is engaged in the treatment for patients suffering from cardiac rhythm diseases by providing physiological stimulation through endocardiac pacing. The Company is engaged in developing and commercializing Wireless Stimulation Endocardially (WiSE), an implantable, cardiac pacing device able to provide stimulation to endocardial (inside the heart) heart tissue for the correction of heart rhythm conditions without requiring the use of leads. WiSE offers leadless solutions for LV Pacing, including cardiac resynchronization therapy (CRT) and conduction system pacing (CSP). The Company also offers CRT devices through the CRM subsegment under the brand names, including Visionist X4 CRT-P, Valitude X4 (CRT-P), Momentum CRT-D, Resonate X4 CRT-D, and Vigilant X4 CRT-D, among others. The Company operates various subsidiaries, which include EBR Systems (AUST) Pty. Ltd. and EBR Systems (UK) Limited, which establish clinical trials in Australia and the United Kingdom, respectively.
More about the company
Last Close Price
0.6683
USD
Average target price
0.9467
USD
Spread / Average Target
+41.65%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**
-40% Limited Time Offer : Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**
BENEFIT NOW **0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**
#252525**/registration/member/**Blanc**1**7**To continue browsing, please register!**#ffffff50**14px**#33d251**